The FDA just opened up access to a promising new Alzheimer’s drug
(Agence France-Presse/ Science Alert) — The US drug regulator gave full approval to a new Alzheimer’s medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.
Leqembi, developed jointly by Japan’s Eisai …